ES8603183A1 - Procedimiento para la preparacion de ergolinas - Google Patents

Procedimiento para la preparacion de ergolinas

Info

Publication number
ES8603183A1
ES8603183A1 ES542071A ES542071A ES8603183A1 ES 8603183 A1 ES8603183 A1 ES 8603183A1 ES 542071 A ES542071 A ES 542071A ES 542071 A ES542071 A ES 542071A ES 8603183 A1 ES8603183 A1 ES 8603183A1
Authority
ES
Spain
Prior art keywords
alkyl
group
double bond
formula
net2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542071A
Other languages
English (en)
Other versions
ES542071A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES542071A0 publication Critical patent/ES542071A0/es
Publication of ES8603183A1 publication Critical patent/ES8603183A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE ERGOLINAS. CONSISTE EN: HACER REACCIONAR UNA ERGOLINA DE FORMULA (II) CON UN REACTIVO ELECTROFILO COMO CLOROSULFONILISOCIANATO SI R2 ES UN GRUPO NITRILO, FLUOROBORATO DE DIMETIL-(METIL-TIO)-SULFONILO (R2 F SME) Y CLORURO DE ACILO, EN PRESENCIA DE UN ACIDO DE LEWIS COMO TRICLORURO DE ALUMINIO, EN UN DISOLVENTE INERTE Y A TEMPERATURA AMBIENTE O INFERIOR PARA OBTENER COMPUESTOS DE FORMULA (I) O SU SAL POR ADICION DE ACIDO CON UN ACIDO FISIOLOGICAMENTE COMPATIBLE COMO ACIDO TARTARICO O ACIDO MALEICO. SIENDO: C8FX9 Y C9FC10 UN ENLACE CC SIMPLE O UN ENLACE CFCX DOBLE, PERO NINGUN ENLACE DOBLE ACUMULADO, Y EL SUSTITUYENTE EN POSICION 8 ESTA EN POSICION A O B CUANDO C8FC9 ES UN ENLACE CC SIMPLE; R2 ES CH, SR Y OTROS; R6 ES ALQUILO C1-4; R8 ES METILO O NH-CO-NET2. SE UTILIZAN EN MEDICINA COMO NEUROLEPTICOS O ANTIDEPRESIVOS.
ES542071A 1984-04-09 1985-04-09 Procedimiento para la preparacion de ergolinas Expired ES8603183A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843413657 DE3413657A1 (de) 1984-04-09 1984-04-09 Neue ergoline

Publications (2)

Publication Number Publication Date
ES542071A0 ES542071A0 (es) 1985-12-16
ES8603183A1 true ES8603183A1 (es) 1985-12-16

Family

ID=6233288

Family Applications (1)

Application Number Title Priority Date Filing Date
ES542071A Expired ES8603183A1 (es) 1984-04-09 1985-04-09 Procedimiento para la preparacion de ergolinas

Country Status (3)

Country Link
CS (1) CS248739B2 (es)
DE (1) DE3413657A1 (es)
ES (1) ES8603183A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE107647T1 (de) * 1984-04-09 1994-07-15 Schering Ag 2-substituierte ergolin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
US4801712A (en) * 1985-06-24 1989-01-31 Eli Lilly And Company 2-Alkyl(or phenyl)thio-6-n-alkylergolines are dopamine D-1 antagonists without D-2 agonist activity
DE3528576A1 (de) * 1985-08-06 1987-02-19 Schering Ag Verfahren zur herstellung von ergolin-thioharnstoffen
DE3528584A1 (de) * 1985-08-06 1987-02-19 Schering Ag Neue 1-alkyl-ergolin-thioharnstoffderivate
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DE3535930A1 (de) * 1985-10-04 1987-04-09 Schering Ag Neue 2-substituierte ergolinderivate
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds
BR112017015510A2 (pt) * 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc composto de fórmula estrutural (i), método de tratamento e/ou prevenção, método de agonização do receptor d2 em um indivíduo, método de antagonização do receptor d3 em um indivíduo, método de agonização do receptor 5-ht1d em um indivíduo, método de agonização do receptor 5-ht1a em um indivíduo, método de agonização seletiva do receptor 5-ht1d em vez do receptor 5-ht1b em um indivíduo, método de agonização seletiva do re-ceptor 5-ht2c em vez do receptor 5-ht2a ou 5-ht2b em um indivíduo, método de agonização do receptor 5-ht2c em um indivíduo, método de fornecimento de atividade antagonista funcional no receptor 5-ht2b ou receptor 5-ht7, e, método de fornecimento de atividade antagonista funcional nos receptores adrenérgicos em um indivíduo
CN113149982A (zh) 2015-01-20 2021-07-23 Xoc制药股份有限公司 麦角灵化合物及其用途
JP2020522504A (ja) 2017-06-01 2020-07-30 エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ 多環式化合物およびそれらの用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1192260B (it) * 1977-07-05 1988-03-31 Simes Derivati di ergoline-2-tioeteri e loro solfossidi
DE3101535A1 (de) * 1981-01-14 1982-08-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
GB2112382B (en) * 1981-11-06 1985-03-06 Erba Farmitalia Ergoline derivatives
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel

Also Published As

Publication number Publication date
ES542071A0 (es) 1985-12-16
DE3413657A1 (de) 1985-10-17
CS248739B2 (en) 1987-02-12

Similar Documents

Publication Publication Date Title
NZ210228A (en) 1h-imidazo (4,5-c quinoline derivatives and bronchodilatory and antiviral compositions containing such
FI932229A0 (fi) Azabicykliska bryggderivat
DE69115379D1 (de) Neue arylethenylenderivate und verfahren zu ihrer herstellung
PL309197A1 (en) Novel compositions based on taxoides
UA11100A (uk) Спосіб одержаhhя феhілалкіламіhів або їх фармакологічhо прийhятhих солей
IE850885L (en) Ergoline derivatives.
IE42409L (en) Acetylene derivatives of aminoacids.
ES8405390A1 (es) Un procedimiento para preparar compuestos de quinolona.
DE3666585D1 (en) P-sulphophenyl alkyl carbonates and their use as bleaching activators
ATE170865T1 (de) Festfase bei oligonukleotidsynthese
US4474600B1 (es)
TW283147B (es)
PE84299A1 (es) Compuestos policiclicos parcialmente hidrogenados
KR850008488A (ko) 디히드로이미다조 [1,2-a] 피리미딘 유도체류의 제조방법
TW278071B (es)
AU8483382A (en) Amino cyclitol derivatives
ES475596A1 (es) Procedimiento para la preparacion de derivados de fenoxial- canolaminas
CA2052020A1 (en) Pradimicin derivatives
DE3464602D1 (en) 4-alkylimidazole derivatives, their preparation and their application
IE830246L (en) Carbacyclin derivatives.
AU6975881A (en) Hydrogenated 1,4 thiazepine (thiazine) dione derivatives
ES552486A0 (es) Un procedimiento para la obtencion de compuestos de 1-oxa-1-dertia cefalosporina.
KR870002118A (ko) 벤질아민 유도체 및 그 제조방법
EP0458347A3 (en) Liquid crystal composition and display device using same
FR2315918A1 (fr) Nouveau derive de dithiodecane, et utilisation therapeutique